Combatting biofilms in potable water systems: A comprehensive overview to ensuring industrial water safety.


Journal

Environmental microbiology reports
ISSN: 1758-2229
Titre abrégé: Environ Microbiol Rep
Pays: United States
ID NLM: 101499207

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 22 06 2023
accepted: 28 09 2023
medline: 27 11 2023
pubmed: 13 10 2023
entrez: 12 10 2023
Statut: ppublish

Résumé

Biofilm formation in industrial potable water systems, encompassing applications such as drinking, emergency showers, firefighting and sanitary appliances, presents a multifaceted challenge that has significant implications for both equipment efficiency and human health. These microbial communities, comprised of bacteria, fungi and protozoa, adhere to surfaces and are embedded within an extracellular matrix, primarily of polysaccharide origin. The formation and persistence of these biofilms can lead to reduced system efficiency and potential health risks due to microbial-induced corrosion, contamination and waterborne pathogens. This review delves into the physicochemical and microbial factors promoting biofilm growth in these systems and elucidates contemporary strategies for their control and eradication. By harnessing advanced methodologies, including state-of-the-art filtration, disinfection techniques and predictive monitoring, stakeholders can proactively address biofilm-related challenges. The emphasis of this comprehensive overview is on the interdisciplinary nature of biofilm growth, combining insights from microbiology, engineering and water chemistry to pave the way for an integrative approach to ensuring consistent industrial water quality.

Identifiants

pubmed: 37827808
doi: 10.1111/1758-2229.13207
pmc: PMC10667638
doi:

Substances chimiques

Drinking Water 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

445-454

Subventions

Organisme : Enerstay Sustainability Pte Ltd (Singapore)
ID : 1/2022 CAA-2003

Informations de copyright

© 2023 The Authors. Environmental Microbiology Reports published by Applied Microbiology International and John Wiley & Sons Ltd.

Références

Int J Biol Sci. 2021 Apr 23;17(7):1769-1781
pubmed: 33994861
Trends Microbiol. 2015 Sep;23(9):567-76
pubmed: 26072043
Beilstein J Nanotechnol. 2016 Oct 18;7:1471-1479
pubmed: 27826522
Environ Microbiol Rep. 2023 Dec;15(6):445-454
pubmed: 37827808
Trends Microbiol. 2019 Nov;27(11):915-926
pubmed: 31420126
ACS Omega. 2020 Aug 28;5(36):22684-22690
pubmed: 32954115
Curr Opin Pharmacol. 2013 Oct;13(5):699-706
pubmed: 23871261
Lett Appl Microbiol. 2000 Jan;30(1):47-52
pubmed: 10728560
J Biomed Nanotechnol. 2020 Oct 1;16(10):1530-1541
pubmed: 33422164
ACS Appl Bio Mater. 2023 Aug 21;6(8):3213-3220
pubmed: 37428894
Biotechnol Prog. 2003 May-Jun;19(3):1038-44
pubmed: 12790676
Microb Biotechnol. 2022 Feb;15(2):548-560
pubmed: 34676986
Biofouling. 2020 Oct;36(9):1129-1148
pubmed: 33349038

Auteurs

Yuanzhe Li (Y)

Carbon Neutrality Research Lab, China Academy of Art, Hangzhou, China.
School of Materials Science & Engineering, Nanyang Technological University, Singapore, Singapore.

Yunzhuo Qu (Y)

College of Polymer Science and Engineering, Sichuan University, Chengdu, China.

Haoyi Yang (H)

NUS College of Design and Engineering, National University of Singapore, Singapore, Singapore.

Xingxin Zhou (X)

Zhuhai College of Science and Technology, Zhuhai, China.

Peng Xiao (P)

Department of Occupational Health and Safety, Mahidol University, Bangkok, Thailand.

Tiancheng Shao (T)

Faculté de l'aménagement, Université de Montréal, Montréal, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH